![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ![]() Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 2002 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations South San Francisco, US HQ |
Employees | Employees 743% increase | Employees 21316% decrease | Employees 58415% increase | Employees 11914% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 116.1 m | Valuation ($) 3.4 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods $76.5m (FY, 2023) | Cost of goods $72.9m (FY, 2025) | Cost of goods N/A |
Net income | Net income ($227.4m) (FY, 2021) | Net income ($13.3m) (FY, 2023) | Net income ($27.1m) (FY, 2025) | Net income ($176.6m) (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 157m |

Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company